Market Research Report
Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis
|Published by||Decision Resources Group - Medtech||Product code||339435|
|Published||Content info||108 Pages
Delivery time: 1-2 business days
|Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis|
|Published: July 23, 2018||Content info: 108 Pages||
Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2027, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe's aging population.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.